Sameer joined Health Innovation Manchester in January 2024 from Zilico Limited, where he was CEO for the company that specialised in cancer diagnostics. At Zilico, Sameer took a new technology, establishing a commercial strategy that included fundraising, and executing this to successfully launch their flagship product in the cancer diagnostics field.
Prior to Zilico, Sameer was CEO of Plasso Technology Ltd, a venture capital-backed company developing research tools and labware for the life sciences. Sameer successfully led the sale of Plasso to Becton Dickinson Inc. Prior to joining Plasso, Sameer was a senior executive, with roles in strategy, business development, HR and mergers and acquisitions at Marconi plc. including a board position in Europe.
As Commercial Director, Sameer is responsible for delivering for Health Innovation Manchester’s commercial plan and developing new and existing partnerships with SMEs and global industry.